Results 201 to 210 of about 32,793 (264)

First use of Trumenba (MenB-fHbp) vaccine to control a nursery outbreak of serogroup B invasive meningococcal disease involving children previously immunised with Bexsero (4CMenB), England, November 2023. [PDF]

Euro Surveill
Foster K, Heymer EJ, Campbell H, Wilson E, Baldasera J, Lucidarme J, Clark SA, Bai X, Ahmad S, Borrow R, Ladhani SN.   +10 more
europepmc   +1 more source

The immunogenicity and safety of a tetravalent measles-mumps-rubella-varicella vaccine when co-administered with conjugated meningococcal C vaccine to healthy children: A phase IIIb, randomized, multi-center study in Italy

, 2016
Paolo Durando, Susanna Esposito, Gianni Bona, Mario Cuccia, Maria Giuseppina Desole, Giuseppe Ferrera, Giovanni Gabutti, Angelo Pellegrino, Filippo Salvini, Ouzama Henry, Michael Povey, Federico Marchetti   +11 more
openalex   +1 more source

Estimating the impact of decreasing vaccination response times for outbreaks of vaccine-preventable diseases in low- and middle-income countries. [PDF]

BMC Glob Public Health
Delport D, Muellenmeister AM, Greig J, Abeysuriya RG, Scott N.   +4 more
europepmc   +1 more source

The impact of introducing meningococcal C/ACWY booster vaccination among adolescents in Germany: a dynamic transmission modelling study. [PDF]

BMC Infect Dis
Günther F, Reinacher U, Chisholm S, Griskaitis M, Höhle M, Scholz S, Schönfeld V, Wichmann O, Harder T, Sandmann FG.   +9 more
europepmc   +1 more source

Novel NOMV-based vaccine against Neisseria meningitidis serogroup B [PDF]

, 2014
Guasch Rodríguez, Marc, Universitat Autònoma de Barcelona. Facultat de Biociències   +1 more
core  

Rollout of the meningococcal A conjugate vaccine in the African meningitis belt countries from 2010 to 2023: progress, challenges, and future directions

André Arsène Bita Fouda, Antoine Durupt, Ado Bwaka, Carol Tevi Benissan, Anderson Latt, Clément Lingani, Mamoudou Harouna Djingarey, Denis Kandolo, Reggis Katsande, Gautier Bikindou, Shibeshi Messeret Eshetu, Joseph Nsiari-Muzeyi Biey, Marcellin Nimpa, Aschalew Teka Bekele, Crépin Hilaire Dadjo, Abdu A. Adamu, Franck Mboussou, Adidja Amani, Charles Shey Wiysonge, Benido Impouma, Marie‐Pierre Préziosi   +20 more
openalex   +1 more source

A Phase 3 study to assess the safety and immunogenicity of a quadrivalent meningococcal conjugate vaccine (MenACYW-TT) co-administered with routine pediatric vaccines in healthy infants in the USA and Puerto Rico. [PDF]

Hum Vaccin Immunother
Campbell JD, Gupta S, Dhingra MS, Zambrano B, Gan L, B'Chir S, Chaix J, Syrkina O, Masson J, Liabis O, Rehm C.   +10 more
europepmc   +1 more source